These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14526268)

  • 1. Acute-phase proteins among patients with type 1 diabetes.
    Gomes MB; Piccirillo LJ; Nogueira VG; Matos HJ
    Diabetes Metab; 2003 Sep; 29(4 Pt 1):405-11. PubMed ID: 14526268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute-phase proteins and microalbuminuria among patients with type 2 diabetes.
    Gomes MB; Nogueira VG
    Diabetes Res Clin Pract; 2004 Oct; 66(1):31-9. PubMed ID: 15364159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.
    Ahmad Khan H
    Acta Diabetol; 2007 Dec; 44(4):193-200. PubMed ID: 17786383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and glycemic control in adults with diabetes.
    King DE; Mainous AG; Buchanan TA; Pearson WS
    Diabetes Care; 2003 May; 26(5):1535-9. PubMed ID: 12716818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
    Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
    Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range.
    Gustavsson CG; Agardh CD
    Eur Heart J; 2004 Dec; 25(23):2120-4. PubMed ID: 15571827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation.
    Schalkwijk CG; Poland DC; van Dijk W; Kok A; Emeis JJ; Dräger AM; Doni A; van Hinsbergh VW; Stehouwer CD
    Diabetologia; 1999 Mar; 42(3):351-7. PubMed ID: 10096789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
    Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes.
    Ganda OP; Arkin CF
    Diabetes Care; 1992 Oct; 15(10):1245-50. PubMed ID: 1425083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia.
    Khan HA; Sobki SH; Khan SA
    Clin Exp Med; 2007 Mar; 7(1):24-9. PubMed ID: 17380302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin Glycosylation Index is not related with blood glucose.
    Merino-Torres JF; Fajardo-Montañana C; Ferrer-García JC; Piñón-Sellés F
    J Diabetes Complications; 2003; 17(5):249-53. PubMed ID: 12954152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated Hemoglobin A(1c) as screening for diabetes mellitus in HIV-infected individuals.
    Eckhardt BJ; Holzman RS; Kwan CK; Baghdadi J; Aberg JA
    AIDS Patient Care STDS; 2012 Apr; 26(4):197-201. PubMed ID: 22324292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.
    Salardi S; Zucchini S; Santoni R; Ragni L; Gualandi S; Cicognani A; Cacciari E
    Diabetes Care; 2002 Oct; 25(10):1840-4. PubMed ID: 12351488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort.
    Jenkins AJ; Rothen M; Klein RL; Moller K; Eldridge L; Zheng D; Durazo-Arvizu R; McGee D; Lackland D; Thorpe SR; Garvey WT; Lyons TJ;
    J Diabetes Complications; 2008; 22(3):153-63. PubMed ID: 18413218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic characteristics and urine albumin excretion rate in relation to pubertal maturation in Type 1 diabetes.
    Riihimaa PH; Knip M; Hirvelä H; Tapanainen P
    Diabetes Metab Res Rev; 2000; 16(4):269-75. PubMed ID: 10934455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood.
    Olsen BS; Sjølie A; Hougaard P; Johannesen J; Borch-Johnsen K; Marinelli K; Thorsteinsson B; Pramming S; Mortensen HB
    J Diabetes Complications; 2000; 14(6):295-300. PubMed ID: 11120452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
    Greaves M; Malia RG; Goodfellow K; Mattock M; Stevens LK; Stephenson JM; Fuller JH
    Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
    Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
    Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
    Davis TM; Cull CA; Holman RR;
    Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Markers of inflammation in type 1 diabetic patients].
    Piccirillo LJ; Gonçalves MF; Clemente EL; Gomes MB
    Arq Bras Endocrinol Metabol; 2004 Apr; 48(2):253-60. PubMed ID: 15640880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.